This inventor holds 1 USPTO granted patent. Top assignee: Chiron Corporation. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Eric S. Groves: Innovator in Controlling Hyperproliferative Diseases
Introduction
Eric S. Groves is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of medical science, particularly in the area of controlling hyperproliferative diseases. His innovative approach has the potential to impact the treatment of various conditions related to cell overgrowth.
Latest Patents
Eric S. Groves holds a patent for a method aimed at controlling hyperproliferative diseases. This method involves the use of a toxin conjugate that binds to an internalizable element of hyperproliferating cells. The conjugate is designed to deliver a toxic moiety specifically to these cells, thereby addressing the overgrowth in the presence of non-proliferating cells. The patent highlights the use of monoclonal antibodies targeting the transferrin receptor, which can be instrumental in managing hyperproliferative diseases affecting the integument and the eye. He has 1 patent to his name.
Career Highlights
Eric S. Groves has been associated with Chiron Corporation, where he has contributed to groundbreaking research and development in the medical field. His work has been pivotal in advancing therapeutic methods that address critical health issues.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues, including L. L. Houston and James W. Larrick. These partnerships have fostered innovation and have been essential in the development of effective medical solutions.
Conclusion
Eric S. Groves exemplifies the spirit of innovation in the medical field, with his work on controlling hyperproliferative diseases showcasing his commitment to improving health outcomes. His contributions continue to pave the way for advancements in medical treatments.